Abstract:Background: Pravastatin is a potent cholesterol-lowering agent; similar to 34% of an oral dose of pravastatin is eliminated unchanged through biliary and urinary excretion. Rifampicin is an Inducer of drug metabolism enzymes, and it affects the activities of transporters involved in pravastatin disposition. Drug-drug interaction between rifampicin and pravastatin is possible because of the effects of rifampicin on the activities of drug transporters.Objective: This study was designed to Investigate the effects of a single oral dose of rifampicin on the pharmacokinetics of pravastatin.Methods: Healthy Chinese male volunteers were recruited for this 2-phase, single-blind, placebo-controlled, crossover study. The subjects were randomly divided into 2 groups to receive either rifampicin or placebo concomitantly with pravastatin. All subjects received a 20-mg oral dose of pravastatin on days 1 and 9, separated by an 8-day washout period. Subjects In the rifampicin group received a single 600-mg oral dose of rifampicin on day 1 and placebo on day 9; those in the placebo group received placebo on day 1 and a single 600-mg oral dose of rifampicin on day 9. High-performance liquid chromatography-tandem mass spectrometry was used to determine plasma concentrations of pravastatin for up to 12 hours after administration.Results: Twelve Volunteers participated in the study (6 per group). The mean (SD) age of the subjects was 20 (2) years (range, 18-25 years). The mean height of the subjects was 174 (4) cm (range, 168-180 cm), and the mean weight was 69.2 (3.7) kg (range, 65-77 kg). The mean pharmacokinetic parameters for pravastatin that changed significantly were as follows (rifampicin and placebo groups, respectively): C(max) (315.7 [227.2] and 115.8 [77.5] ng . mL(-1) [P = 0.009]); AUC(0-12) (604.8 [73.3] and 259.0 [133.4] ng . h . mL(-1) [P < 0.001]); AUC(0-infinity) (623.3 [248.8] and 275.1 [58.5] ng . h . mL(-1) [P < 0.001]); and apparent oral clearance (CL/F) (0.52 [0.18] and 130 [0.58] L . h(-1) . kg(-1) [P < 0.001]). No significant changes in the T(max) or t(1/2) of pravastatin were observed. All Subjects tolerated pravastatin well during both phases of the study, with Or Without coadministration of rifampicin. None of the Subjects withdrew from the study.Conclusion: Coadministration of a single oral dose of rifampicin significantly increased the plasma concentration of pravastatin in this group of healthy Chinese male subjects. (Clin Ther. 2009;31:1256-1263) (C) 2009 Excerpta Medica Inc.

Pharmacokinetics and relative bioavailability of rifapentine

Clinical pharmacokinetic study on Rifapentine

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Pharmacokinetics of rifampin in healthy volunteers after a high oral dose

Evaluation of the Bioequivalence and Pharmacokinetics of Two Formulations of Rizatriptan after Single Oral Administration in Healthy Volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Pharmacokinetics and bioequivalence of roxithromycin capsules in healthy volunteers

Evaluation of rifampicin bioequivalence in fixed-dose combinations using the WHO/IUATLD recommended protocol

A Study of the Bioequivalence of Fleroxacin Tablets in Healthy Chinese Volunteers

Study on Bioequivalence of Risperidone Tablets

Bioequivalence of Imported and Domestic Risperidone Film-Coated Tablets in Healthy Volunteers

Study of the Bioequivalence of Isopropiram Fumarate Tablets in Healthy Volunteers

Pharmacokinetics and Relative Bioavailablity of Domestic Penicillin V Dispersion Tablet

Relative bioavailability of mycophenolate mofetil capsules in healthy volunteers

Bioequivalence of Risperidone Orally Disintegrating Tablets in Healthy Volunteers

The relative bioavailability of two kinds of fluconazole dispersible tablets and fluconazole capsules in healthy volunteers

Effects of a Concomitant Single Oral Dose of Rifampicin on the Pharmacokinetics of Pravastatin in a Two-Phase, Randomized, Single-Blind, Placebo-Controlled, Crossover Study in Healthy Chinese Male Subjects.

Relative Bioavailablity of Micronised Fenofibrate Dispersion Table in Human Volunteers

Bioequivalence study of two risedronate sodium film-coated tablet formulations in healthy volunteers

Study on Relative Bioavailability of Two Flunarizine Hydrochloride Capsules

Relative Bioavailability and Bioequivalence of Metforphin Hydrochloride Extended-Released and Immediate-Released Tablets in Healthy Chinese Volunteers